HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fortuna Ponte Selected Research

N,N-dimethylaniline

12/2019Glutathione activation of an organometallic half-sandwich anticancer drug candidate by ligand attack.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fortuna Ponte Research Topics

Disease

9Neoplasms (Cancer)
04/2024 - 08/2019
3Adenocarcinoma
07/2021 - 12/2020
2Lung Neoplasms (Lung Cancer)
12/2020 - 05/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2021
1Photosensitivity Disorders (Photodermatitis)
06/2018

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
05/2020 - 08/2019
1NAD (NADH)IBA
04/2024
1LigandsIBA
10/2023
1RutheniumIBA
09/2022
1Betaine (C.B.B.)FDA Link
07/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2020
1Carboplatin (JM8)FDA LinkGeneric
12/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2020
1IridiumIBA
05/2020
1DNA (Deoxyribonucleic Acid)IBA
12/2019
1N,N-dimethylanilineIBA
12/2019
14-cymene (p-cymene)IBA
12/2019
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
06/2018
1BromineIBA
06/2018

Therapy/Procedure

4Therapeutics
07/2021 - 08/2019
1Photochemotherapy (Photodynamic Therapy)
06/2018